Intravenous Nitroglycerin for Retained Placenta Extraction: a Multicenter Study

Summary

Primary objective The primary objective of this study is to see whether intravenous (IV) NTG 100-200 microgram can effectively help extract retained placenta as compared to placebo, in a randomized controlled multicenter study. Secondary objective is to compare the hypotensive effects of NTG as compared to placebo, including others side effects such as headache, blood loss, or others.

Timeline

Start

2008-02

Primary completion

2010-12

Completion

2010-12

Drugs

Indications